Answer
It is unknown whether guanfacine or its metabolites pass into human breast milk; animal studies show milk excretion, so infant risk cannot be excluded and a decision is needed between breastfeeding and guanfacine therapy, weighing breastfeeding benefits for the child and treatment benefits for the woman.
Sources for this answer
- Intuniv 4 mg prolonged-release tabletsTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked